Phibro Animal Health (NASDAQ:PAHC) Raised to “Buy” at StockNews.com

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHCFree Report) from a hold rating to a buy rating in a research note issued to investors on Friday morning.

Separately, BNP Paribas assumed coverage on shares of Phibro Animal Health in a research report on Thursday, December 7th. They issued an underperform rating and a $9.00 price objective for the company.

Check Out Our Latest Analysis on PAHC

Phibro Animal Health Price Performance

PAHC opened at $12.93 on Friday. The company has a quick ratio of 1.60, a current ratio of 3.12 and a debt-to-equity ratio of 1.66. Phibro Animal Health has a 12 month low of $9.40 and a 12 month high of $15.98. The company has a fifty day simple moving average of $12.18 and a 200 day simple moving average of $11.74. The stock has a market cap of $523.67 million, a P/E ratio of 35.92, a P/E/G ratio of 4.83 and a beta of 0.75.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The business had revenue of $249.90 million during the quarter, compared to analysts’ expectations of $242.91 million. On average, research analysts expect that Phibro Animal Health will post 1.12 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Wednesday, March 6th were paid a dividend of $0.12 per share. The ex-dividend date was Tuesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.71%. Phibro Animal Health’s dividend payout ratio is 133.33%.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP lifted its stake in Phibro Animal Health by 165.9% in the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after purchasing an additional 102,793 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in Phibro Animal Health by 27.9% in the 4th quarter. Goldman Sachs Group Inc. now owns 195,289 shares of the company’s stock valued at $2,261,000 after purchasing an additional 42,626 shares during the last quarter. Legal & General Group Plc lifted its stake in Phibro Animal Health by 2.7% in the 4th quarter. Legal & General Group Plc now owns 51,224 shares of the company’s stock valued at $593,000 after purchasing an additional 1,364 shares during the last quarter. Barclays PLC lifted its stake in Phibro Animal Health by 73.4% in the 4th quarter. Barclays PLC now owns 61,812 shares of the company’s stock valued at $716,000 after purchasing an additional 26,174 shares during the last quarter. Finally, Voya Investment Management LLC lifted its stake in Phibro Animal Health by 29.9% in the 4th quarter. Voya Investment Management LLC now owns 23,305 shares of the company’s stock valued at $270,000 after purchasing an additional 5,358 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

See Also

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.